Analyst Consensus ?
ConsensusBuy26 ratings
Bullish1246.2%
Neutral1453.8%
Bearish00.0%
Raymond James Financial, Inc. · RJF · FY2026 Q2 · Calendar Q2 2026
Raymond James posts record Q2 revenue of $3.86B, EPS beats; securities loans up 31%
Raymond James' record Q2 FY2026 results — driven by adviser recruiting, fee-based asset inflows, securities-based lending growth and a rebounding capital-markets pipeline — support a constructively held view on the shares. Continued net-new-asset generation and steady capital return (buybacks plus acquisitions) underpin durable earnings, while declining pretax yields from rate cuts and a rising compensation ratio are the main near-term margin offsets. Consensus price target of $177.33 versus the $159.87 current price implies modest upside; the stock traded roughly in line with the benchmark around the report.
Reported After market closeNYSEFinancial Services
$30.50B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$2.83
Consensus $2.76
EPS surprise
+2.5%
Reported versus consensus
Reported revenue
$3.86B
Consensus $3.85B
Revenue surprise
+0.4%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
-0.7%
Event window
SPY move
-0.4%
Same window
Abnormal move
-0.3%
Stock minus SPY
Volume
2.3×
Versus trailing sessions
Subsequent drift
-1.9%
Up to 20 sessions
RJFSPY benchmark
Ask FN2 about RJF FY2026 Q2
Transcript, numbers and history already loaded
Why did RJF fall 0.7% after beating EPS estimates in FY2026 Q2?What changed in RJF's guidance and outlook in FY2026 Q2?Give me the bull and bear case for RJF after FY2026 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Q2 FY2026 delivered record revenue of $3.86B (+13% YoY) and record pretax income (+10% YoY). EPS of $2.83 topped the $2.76 estimate by ~2.5%. Adviser recruiting produced 7% annualized net new assets in the first half, securities-based loans rose 31% YoY (bank loans $54.8B), technology/AI spend exceeded $1.1B, the GreensLedge acquisition closed, and Clark Capital's close is pending. Guidance was maintained with a confident tone; the shares' move around the print was minimal versus the market.
Guidance delta
maintained
Key takeaways
- Record Q2 revenue of $3.86B, up 13% YoY, and record pretax income up 10% YoY
- EPS of $2.83 beat the $2.76 Street estimate, a ~2.5% surprise
- Adviser recruiting delivered 7% annualized net new assets in the first half
- Securities-based loans grew 31% YoY, lifting total bank loans to $54.8B
- Technology and AI spend of >$1.1B underpins efficiency; GreensLedge closed and Clark Capital pending
Management priorities
- Expand the proprietary AI operations agent to more advisers and explore agentic AI
- Finalize and integrate the Clark Capital acquisition
- Maintain or increase technology spend to enhance adviser tools
- Continue the share repurchase program and broader capital return
- Grow the securities-based lending franchise and fee-based asset base
Follow RJF with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$159.87Current
$123Low
$159.71Average
$205High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 25, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Hold | Hold | Maintain | Sep 1, 2026 |
| Argus Research | Buy | Buy | Maintain | Jul 30, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 27, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 23, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jul 23, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 23, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 23, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 10, 2026 |
| Jefferies | Hold | Hold | Maintain | Apr 6, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Dec 10, 2025 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Oct 23, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Oct 23, 2025 |
| Citigroup | Neutral | Neutral | Maintain | Sep 22, 2025 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 11, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 3, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jul 8, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 27, 2023 |
| Seaport Global | Buy | Neutral | Upgrade | Jan 28, 2022 |
| Compass Point | Neutral | Buy | Downgrade | May 1, 2020 |
| Buckingham Research | Buy | Buy | Maintain | Oct 26, 2018 |
| Buckingham | Buy | Buy | Maintain | Oct 26, 2018 |
| Keefe Bruyette & Woods | Outperform | Market Perform | Upgrade | Feb 27, 2018 |
| Nomura | Buy | Buy | Maintain | Jul 13, 2017 |
| Macquarie | Neutral | Neutral | Maintain | Jan 22, 2016 |
| Susquehanna | Positive | Positive | Maintain | Jul 15, 2015 |
| S&P Capital IQ | Strong Buy | Buy | Upgrade | Jul 9, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $159.87. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Raymond James | Analyst unavailable | $160 | $178.17 | +0.1% | Sep 1, 2026 |
| Truist Financial | David Smith | $188 | $178.17 | +17.6% | Sep 1, 2026 |
| UBS | Analyst unavailable | $184 | $172.75 | +15.1% | Jul 27, 2026 |
| Raymond James | Michael Cho | $179 | $164.91 | +12.0% | Jul 23, 2026 |
| Raymond James | Brennan Hawken | $175 | $165.16 | +9.5% | Jul 23, 2026 |
| Raymond James | Devin Ryan | $205 | $168.01 | +28.2% | Jul 23, 2026 |
| Raymond James | Analyst unavailable | $174 | $169.45 | +8.8% | Jul 10, 2026 |
| Raymond James | Analyst unavailable | $192 | $169.9 | +20.1% | Jul 9, 2026 |
| Raymond James | Analyst unavailable | $200 | $165.35 | +25.1% | Jul 9, 2026 |
| UBS | Michael Brown | $175 | $166.58 | +9.5% | Jul 8, 2026 |
| Raymond James | Analyst unavailable | $155 | $143.22 | -3.0% | May 28, 2026 |
| UBS | Analyst unavailable | $166 | $156.16 | +3.8% | Apr 23, 2026 |
| Raymond James | Analyst unavailable | $172 | $155.91 | +7.6% | Apr 23, 2026 |
| Raymond James | Michael Cyprys | $171 | $145.35 | +7.0% | Apr 10, 2026 |
| Raymond James | Analyst unavailable | $156 | $148.14 | -2.4% | Apr 9, 2026 |
| Raymond James | Analyst unavailable | $165 | $147.82 | +3.2% | Apr 8, 2026 |
| UBS | Analyst unavailable | $158 | $147.82 | -1.2% | Apr 8, 2026 |
| Raymond James | Analyst unavailable | $198 | $165.86 | +23.9% | Feb 1, 2026 |
| Raymond James | Analyst unavailable | $191 | $169.02 | +19.5% | Jan 28, 2026 |
| Raymond James | Michael Cyprys | $187 | $163.01 | +17.0% | Dec 22, 2025 |
| UBS | Michael Brown | $176 | $166.94 | +10.1% | Dec 11, 2025 |
| Raymond James | Analyst unavailable | $196 | $165.79 | +22.6% | Dec 10, 2025 |
| Raymond James | Analyst unavailable | $194 | $164.98 | +21.3% | Oct 23, 2025 |
| Raymond James | Brennan Hawken | $182 | $166.04 | +13.8% | Oct 23, 2025 |
| Raymond James | Analyst unavailable | $181 | $166.04 | +13.2% | Oct 23, 2025 |
| Raymond James | Devin Ryan | $190 | $162.06 | +18.8% | Oct 23, 2025 |
| Raymond James | Devin Ryan | $185 | $165.15 | +15.7% | Oct 9, 2025 |
| Raymond James | Analyst unavailable | $178 | $167.64 | +11.3% | Oct 7, 2025 |
| Raymond James | Analyst unavailable | $173 | $165.9 | +8.2% | Oct 2, 2025 |
| Raymond James | Analyst unavailable | $184 | $168.6 | +15.1% | Oct 1, 2025 |
| Raymond James | Devin Ryan | $180 | $159.31 | +12.6% | Jul 14, 2025 |
| Raymond James | Craig Siegenthaler | $159 | $137.26 | -0.5% | Apr 24, 2025 |
| Raymond James | Analyst unavailable | $161 | $144.19 | +0.7% | Mar 4, 2025 |
| Raymond James | Christopher Allen | $170 | $154.21 | +6.3% | Jan 10, 2025 |
| Raymond James | William Kirk | $150 | $149.05 | -6.2% | Oct 30, 2024 |
| Raymond James | Michael Cyprys | $132 | $136.51 | -17.4% | Oct 17, 2024 |
| Raymond James | Devin Ryan | $146 | $124.9 | -8.7% | Oct 9, 2024 |
| Wells Fargo | Christopher Harris | $138 | $115.95 | -13.7% | Sep 11, 2024 |
| Raymond James | Daniel Fannon | $123 | $119.51 | -23.1% | Jul 8, 2024 |
| Raymond James | William Kirk | $130 | $125.36 | -18.7% | May 24, 2024 |
| Raymond James | Bill Katz | $126 | $123.39 | -21.2% | May 24, 2024 |
| Seaport Global | Jim Mitchell | $139 | $129.61 | -13.1% | Apr 4, 2024 |
| Raymond James | Mark McLaughlin | $145 | $128.43 | -9.3% | Apr 2, 2024 |
| Raymond James | Mark McLaughlin | $122 | $106.83 | -23.7% | Sep 11, 2023 |
| UBS | Analyst unavailable | $125 | $110.71 | -21.8% | Jan 9, 2023 |
| Raymond James | Analyst unavailable | $130.07 | $67.71 | -18.6% | Apr 29, 2022 |
| Morgan Stanley | Manan Gosalia | $128 | $98.45 | -19.9% | Mar 14, 2022 |
Track every rating change on RJF the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationRaymond James Financial, Inc. operates as a comprehensive financial services firm, extending a wide array of services to individuals, businesses, and governmental entities throughout the United States, Canada, and Europe. Its diverse operations are categorized into several key segments: Private Client Group, Capital Markets, Asset Management, Banking, and an "Other" category. The Private Client Group division equips clients with various investment solutions, personalized portfolio management, a selection of insurance and annuity products, and mutual funds. This segment also provides essential backing to third-party product partners, covering aspects like sales and marketing support, distribution, accounting, and general administrative assistance. Additionally, it facilitates margin loans and offers securities borrowing and lending services.…
Historical context
All RJF earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| PUK Prudential plc | FY2026 Q2 · Calendar Q3 2026 | -40.9% | -0.5% | Prudential sustains growth and capital returns focus in H1 2026 |
| CM Canadian Imperial Bank of Commerce | FY2026 Q3 · Calendar Q3 2026 | +8.9% | -2.8% | CIBC Q3: Broad growth, resilient credit and expanded AI rollout |
| TD The Toronto-Dominion Bank | FY2026 Q3 · Calendar Q3 2026 | +13.8% | +1.4% | TD emphasizes growth investments alongside disciplined capital management |
| RY Royal Bank of Canada | FY2026 Q3 · Calendar Q3 2026 | +6.2% | -1.3% | RBC reports record Q3 earnings while investing for growth |
| AFRM Affirm Holdings, Inc. | FY2026 Q4 · Calendar Q3 2026 | +1230.3% | +0.3% | Affirm's most profitable quarter shifts focus to product execution |
Latest beats and misses
Who reports nextBeat on EPS
- SNXFY2026 Q3 · September 24, 2026+20.9% EPS-9.9% move
- DRIFY2027 Q1 · September 24, 20260.0% EPS-3.0% move
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
- GISFY2027 Q1 · September 23, 2026+4.6% EPS+1.0% move
- AZOFY2026 Q4 · September 22, 2026+3.6% EPS+3.3% move
Get the RJF recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-09-25T21:21:04.423614+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-25T21:21:04.420543+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-25. For educational purposes only; not investment advice.